16466 Predictors of maintenance of response in patients with moderate to severe atopic dermatitis after oral Janus kinase 1 selective inhibitor abrocitinib interruption
Gooderham, Melinda J., Girolomoni, Giampiero, O’Neil Moore, Julian, Silverberg, Jonathan I., Curto, Madelyn, Zhang, Weidong, DiBonaventura, Marco, Valdez, Hernan, Valdez, Hernan
Published in Journal of the American Academy of Dermatology (01.12.2020)
Published in Journal of the American Academy of Dermatology (01.12.2020)
Get full text
Journal Article